Socialiya - Entertainment. Knowledge. Community.
Ipsen to buy blood cancer company Kartos Therapeutics for $450M upfront

Ipsen will pay $450 million upfront to buy Kartos Therapeutics and its MDM2 protein-targeting drug c...

BUSINESS NEWS June 29, 2026

Ipsen to buy blood cancer company Kartos Therapeutics for $450M upfront

Ipsen will pay $450 million upfront to buy Kartos Therapeutics and its MDM2 protein-targeting drug candidate that it in-licensed from Amgen back in 2016.

2 views 0 likes 0 comments
Share:
Ipsen will pay $450 million upfront to buy Kartos Therapeutics and its MDM2 protein-targeting drug candidate that it in-licensed from Amgen back in 2016.

Author: Endpoints News

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya